CapsoVision financials
$6.69−3.32%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 |
|---|---|---|---|---|
| Revenue | $3.6M | $2.8M | $3.9M | $3.5M |
| Gross profit | $1.9M | $1.3M | $2.0M | $1.9M |
| Gross margin | 51.4% | 47.6% | 49.9% | 54.1% |
| Operating income | -$7.6M | -$7.1M | -$7.5M | -$8.0M |
| Net income | -$7.5M | -$7.0M | -$7.4M | -$7.9M |
| Net margin | −205.4% | −251.9% | −188.7% | −223.9% |
| Diluted EPS | $-0.15 | $-0.15 | $-0.16 | $-0.17 |
| EBITDA | -$7.5M | -$7.0M | -$7.1M | -$8.0M |
| Operating cash flow | -$8.4M | -$6.1M | -$7.7M | -$5.7M |
| Free cash flow | -$8.4M | -$6.1M | -$7.7M | -$5.7M |
| Diluted shares | 49.9M | 47.5M | 47.6M | 46.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|
| Cash & equivalents | $9.1M | $17.9M | $10.1M | $17.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $18.6M | $25.9M | $18.2M | $25.7M |
| Total liabilities | $5.4M | $5.7M | $4.9M | $5.2M |
| Shareholders' equity | $13.2M | $20.2M | $13.3M | $20.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology